Pharmasset Inc

(

VRUS

) pushed the Drugs industry lower today making it today's featured Drugs loser. The industry as a whole closed the day up 3.6%. By the end of trading, Pharmasset Inc fell $1.44 (-1.1%) to $130.99 on heavy volume. Throughout the day, 6.8 million shares of Pharmasset Inc exchanged hands as compared to its average daily volume of 1.9 million shares. The stock ranged in price between $130.40-$132.50 after having opened the day at $132.50 as compared to the previous trading day's close of $132.43. Other company's within the Drugs industry that declined today were:

Poniard Pharmaceuticals Inc

(

PARDD

), down 14.4%,

Horizon Pharma Inc

(

HZNP

), down 12.7%,

Marina Biotech Inc

(

MRNA

), down 9.1%, and

AspenBio Pharma Inc

(

APPY

), down 8.1%.

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset Inc has a market cap of $10.09 billion and is part of the

health care

sector. Shares are up 508% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Pharmasset as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, weak operating cash flow and deteriorating net income.

On the positive front,

PROLOR Biotech Inc

(

PBTH

), up 21.4%,

Progenics Pharmaceuticals Inc

(

PGNX

), up 20.9%,

Amicus Therapeutics Inc

(

FOLD

), up 19.2%, and

Sangamo BioSciences Inc

(

SGMO

), up 18.4%, were all gainers within the drugs industry with

Johnson & Johnson

(

JNJ

) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider

SPDR S&P Pharmaceuticals ETF

(

XPH

) while those bearish on the drugs industry could consider

ProShares UltraShort Nasdaq Biotech

(

BIS

).

null